USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/3344
Title: Tumorile pancreatice, ampulare şi a papilei duodenale mari -particularităţile de diagnostic, atitudine terapeutică
Other Titles: Tumors of pancreas, ampulla and major duodenal papilla pecularities of diagnosis, therapeutical atitude
Authors: Hotineanu, Vladimir
Hotineanu, Adrian
Cazac, Anatol
Bogdan, Valeriu
Cotoneţ, Alic
Pripa, Valeriu
Cărăruş, Ion
Issue Date: 2008
Publisher: CEP Medicina
Citation: HOTINEANU, V., HOTINEANU, A. et al. Tumorile pancreatice, ampulare şi a papilei duodenale mari -particularităţile de diagnostic, atitudine terapeutică. In: Anale Științifice ale USMF “Nicolae Testemiţanu”. Ed. a 9-a. Chişinau: СEP Medicina, 2008, Vol. 4: Probleme clinico-chirurgicale, pp. 19-24.
Abstract: Study prezents retrospective analyzis of 860 patients with pancreatic tumors, of ampul and major duodenal papilla (MDP), treated during the period 1990-2008 years. Pathomorphologycal examination recorded the following results: acinocelular cancer – 10(1,16%), adenocarcinoma – 643(74,78%), cystadenocarcinoma – 99(11,51%), carcinoid – 31(3,6%, cancer of MDP – 70(8,14%) ampular cancer – 7(0,8%). Studiul prezintă o analiză retrospectivă a unui lot de 860 pacienţi cu tumori pancreatice, ampulare şi a PDM trataţi în perioada 1990-2008. Examenul patomorfologic realizat a condus la constatarea următoarelor rezultate: cancer acinocelular -10(1,16%), adenocarcinom pancreatic – 643(74,78%), chistadenocarcinom pancreatic – 99(11,51%), carcinoid pancreatic – 31(3,6%), cancer PDM-70(8,14%), cancer ampular – 7(0,81%). Supravieţuirea maximală pentru cazurile de carcinoid pancreatic a fost de 8 ani, pentru cancer pancreatic supravieţuirea medie pe grup de 26 luni, supravieţuire maximală de 4 ani, pentru cancer a PDM-30 luni, supravieţuire maximală - 4,5ani.
URI: http://repository.usmf.md/handle/20.500.12710/3344
Appears in Collections:Chirurgie generală, oncologie, neurochirurgie



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback